Table 2.
Correlation between cQCT measures and aBMD by DXA in subjects and controls
cQCT measures | Controls |
All affected subjects |
||||||
---|---|---|---|---|---|---|---|---|
LS aBMD | TH aBMD | FN aBMD | DR aBMD | LS aBMD | TH aBMD | FN aBMD | DR aBMD | |
Spine | ||||||||
LS total vBMD | 0.30 | 0.13 | −0.01 | 0.15 | 0.75a | 0.47b | 0.55b | 0.34c |
LS Trabecular vBMD | 0.31 | 0.18 | 0.07 | 0.14 | 0.75a | 0.46b | 0.54b | 0.34c |
VBCSA | 0.06 | 0.32 | 0.36c | 0.19 | 0.50b | 0.36c | 0.27 | 0.37c |
Left hip | ||||||||
PF total vBMD | 0.02 | 0.51b | 0.24 | 0.43c | 0.38c | 0.74a | 0.73a | 0.20 |
PF trabecular vBMD | 0.10 | 0.36c | 0.20 | 0.17 | 0.45b | 0.84a | 0.81a | 0.30 |
PF cortical vBMD | −0.05 | 0.38c | 0.18 | 0.48b | 0.29 | 0.26 | 0.29 | 0.05 |
FN total vBMD | 0.06 | 0.30 | 0.21 | 0.31 | 0.38c | 0.64a | 0.67a | 0.13 |
FN trabecular vBMD | 0.16 | 0.09 | 0.06 | 0.02 | 0.59b | 0.79a | 0.85a | 0.25 |
FN cortical vBMD | 0.06 | 0.34 | 0.28 | 0.38c | 0.15 | 0.17 | 0.21 | −0.06 |
FNCS | 0.36c | 0.24 | 0.43c | −0.06 | 0.57b | 0.43b | 0.38c | 0.48b |
Right hip | ||||||||
PF total vBMD | −0.08 | 0.40c | 0.11 | 0.32 | 0.32 | 0.75a | 0.69a | 0.17 |
PF trabecular vBMD | 0.06 | 0.23 | 0.11 | 0.02 | 0.36c | 0.77a | 0.73a | 0.34c |
PF Cortical vBMD | −0.12 | 0.32 | 0.07 | 0.39c | 0.19 | 0.22 | 0.21 | 0.04 |
FN Total vBMD | −0.03 | 0.20 | 0.07 | 0.14 | 0.36c | 0.66a | 0.68a | 0.14 |
FN trabecular vBMD | 0.21 | 0.12 | 0.10 | −0.11 | 0.48b | 0.73a | 0.75a | 0.24 |
FN cortical vBMD | 0.02 | 0.28 | 0.19 | 0.27 | 0.14 | 0.15 | 0.16 | −0.01 |
FNCS | 0.22 | 0.18 | 0.32 | −0.04 | 0.57b | 0.44b | 0.43c | 0.54b |
TH, Total hip; FN, femoral neck; DR, distal radius; PF, proximal femur.
Significant correlations are shown in bold.
P < 0.001.
P < 0.01.
P < 0.05.